Cumberland Pharmaceuticals (CPIX) EPS (Diluted) Growth (5y) (2015 - 2026)
Cumberland Pharmaceuticals (CPIX) EPS (Diluted) Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - |
| 10 | Cumberland Pharmaceuticals | 116.48 Mn | 112.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -34.28% |
| Mar 31, 2026 | -53.28% |
| Dec 31, 2025 | -29.60% |
| Sep 30, 2025 | -35.31% |
| Jun 30, 2025 | -24.69% |
| Mar 31, 2025 | 9.26% |
| Dec 31, 2024 | -23.46% |
| Sep 30, 2024 | -26.55% |
| Jun 30, 2024 | -28.99% |
| Mar 31, 2024 | -30.74% |
| Dec 31, 2023 | -2.71% |
| Sep 30, 2023 | 6.97% |
| Jun 30, 2023 | 26.55% |
| Mar 31, 2023 | 15.75% |
| Dec 31, 2021 | 22.08% |
| Sep 30, 2021 | 41.98% |
| Jun 30, 2021 | 60.95% |
| Mar 31, 2021 | 31.80% |
| Dec 31, 2020 | 50.21% |
| Sep 30, 2020 | 48.32% |